Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Extrahepatic metastasis of hepatocellular carcinoma arising from a hepatic adenoma without concurrent intrahepatic recurrence.

Poddar N, Ramlal R, Ravulapati S, Devlin SM, Gadani S, Vidal CI, Cao D, Befeler AS, Lai J.

Curr Oncol. 2017 Aug;24(4):e333-e336. doi: 10.3747/co.24.3494. Epub 2017 Aug 31.

2.

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.

Cholankeril G, Patel R, Khurana S, Satapathy SK.

World J Hepatol. 2017 Apr 18;9(11):533-543. doi: 10.4254/wjh.v9.i11.533. Review.

3.

Hepatocellular adenoma: when and how to treat? Update of current evidence.

Thomeer MG, Broker M, Verheij J, Doukas M, Terkivatan T, Bijdevaate D, De Man RA, Moelker A, IJzermans JN.

Therap Adv Gastroenterol. 2016 Nov;9(6):898-912. Epub 2016 Sep 28. Review.

4.

Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

Inayat F, Ur Rahman Z, Hurairah A.

Cureus. 2016 Aug 29;8(8):e754.

5.

Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver?

Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M.

World J Hepatol. 2016 Sep 18;8(26):1110-5. doi: 10.4254/wjh.v8.i26.1110.

6.

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.

Roncalli M, Sciarra A, Tommaso LD.

Clin Mol Hepatol. 2016 Jun;22(2):199-211. doi: 10.3350/cmh.2016.0101. Epub 2016 May 18. Review.

7.

Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice.

Shin S, Wangensteen KJ, Teta-Bissett M, Wang YJ, Mosleh-Shirazi E, Buza EL, Greenbaum LE, Kaestner KH.

Hepatology. 2016 Oct;64(4):1163-1177. doi: 10.1002/hep.28602. Epub 2016 May 28.

8.

Hepatocellular adenoma: An update.

Vijay A, Elaffandi A, Khalaf H.

World J Hepatol. 2015 Nov 8;7(25):2603-9. doi: 10.4254/wjh.v7.i25.2603. Review.

9.

Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival.

Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U.

Clin Epigenetics. 2015 Oct 15;7:110. doi: 10.1186/s13148-015-0145-6. eCollection 2015.

10.

Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis.

Goltz D, Fischer HP.

Int J Mol Sci. 2015 Sep 2;16(9):20994-1007. doi: 10.3390/ijms160920994. Review.

11.

Malignant transformation of hepatocellular adenoma: how frequently does it happen?

Kudo M.

Liver Cancer. 2015 Mar;4(1):1-5. doi: 10.1159/000367726. No abstract available.

12.

Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report.

Solbach P, Potthoff A, Raatschen HJ, Soudah B, Lehmann U, Schneider A, Gebel MJ, Manns MP, Vogel A.

BMC Gastroenterol. 2015 May 20;15:60. doi: 10.1186/s12876-015-0288-0.

13.

Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma.

Khanna M, Ramanathan S, Fasih N, Schieda N, Virmani V, McInnes MD.

Insights Imaging. 2015 Jun;6(3):347-62. doi: 10.1007/s13244-015-0399-8. Epub 2015 Mar 20.

14.

Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.

Leung C, Yeoh SW, Patrick D, Ket S, Marion K, Gow P, Angus PW.

World J Gastroenterol. 2015 Jan 28;21(4):1189-96. doi: 10.3748/wjg.v21.i4.1189.

15.

Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.

Inoue M, Takahashi Y, Fujii T, Kitagawa M, Fukusato T.

World J Gastroenterol. 2014 Dec 14;20(46):17541-51. doi: 10.3748/wjg.v20.i46.17541.

16.

Histopathology of hepatocellular carcinoma.

Schlageter M, Terracciano LM, D'Angelo S, Sorrentino P.

World J Gastroenterol. 2014 Nov 21;20(43):15955-64. doi: 10.3748/wjg.v20.i43.15955. Review.

17.

Malignant transformation of hepatocellular adenoma over a decade.

Tokoro T, Kato Y, Sugioka A, Mizoguchi Y.

BMJ Case Rep. 2014 Sep 22;2014. pii: bcr2014205261. doi: 10.1136/bcr-2014-205261.

18.

Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.

Kakar S, Grenert JP, Paradis V, Pote N, Jakate S, Ferrell LD.

Mod Pathol. 2014 Nov;27(11):1499-1509. doi: 10.1038/modpathol.2014.50. Epub 2014 Apr 18.

19.

Next-generation genomic profiling of hepatocellular adenomas: a new era of individualized patient care.

Marquardt JU, Thorgeirsson SS.

Cancer Cell. 2014 Apr 14;25(4):409-11. doi: 10.1016/j.ccr.2014.03.032.

20.

Liver masses: a clinical, radiologic, and pathologic perspective.

Venkatesh SK, Chandan V, Roberts LR.

Clin Gastroenterol Hepatol. 2014 Sep;12(9):1414-29. doi: 10.1016/j.cgh.2013.09.017. Epub 2013 Sep 18. Review.

Supplemental Content

Support Center